Annual report pursuant to Section 13 and 15(d)

Statements of Shareholders'/Members' Equity Statements of Shareholders/Members' Equity

v2.4.0.8
Statements of Shareholders'/Members' Equity Statements of Shareholders/Members' Equity (USD $)
In Thousands, except Share data
Total
USD ($)
Retained Earnings [Member]
USD ($)
Accumulated Other Comprehensive Income (Loss) [Member]
USD ($)
Common Stock [Member]
USD ($)
Restricted Stock Units (RSUs) [Member]
Performance Shares [Member]
Balance, beginning of period at Mar. 31, 2011 $ 126,532 $ (14,940) $ 10,031 $ 131,441    
Common stock, shares outstanding, beginning of period at Mar. 31, 2011       24,933,407,000    
Net income (loss) 12,030 12,030        
Issuance of common stock for cash, shares       4,575,098,000    
Issuance of common stock for cash 48,459     48,459    
Stock-based compensation expense 6,514     6,514    
Excess tax deduction from stock options 2,181          
Net income (loss) 12,030          
Foreign curency translation adjustment (6,517)   (6,517)      
Foreign provision 12,551          
Other (152)   (152)      
Issuance of common stock in exercise of stock options, shares       683,443,000    
Issuance of common stock in exercise of stock options 3,433     3,433    
Issuance of restricted stock as deferred compensation to employees and directors       16,136,000    
Excess tax deduction from stock options exercises 2,181     2,181    
Balance, end of period at Mar. 31, 2012 192,480 (2,910) 3,362 192,028    
Common stock, shares outstanding, end of period at Mar. 31, 2012       30,208,084,000    
Net income (loss) 26,974 26,974        
Stock-based compensation expense 1,341     1,341    
Excess tax deduction from stock options 4,131          
Net income (loss) 26,974          
Foreign curency translation adjustment (4,133)   (4,133)      
Foreign provision 12,352          
Other (304)   (304)      
Issuance of common stock in exercise of stock options, shares       1,086,486,000    
Issuance of common stock in exercise of stock options 5,558     5,558    
Issuance of restricted stock as deferred compensation to employees and directors       13,012,000    
Excess tax deduction from stock options exercises 4,131     4,131    
Balance, end of period at Mar. 31, 2013 226,047 24,064 (1,075) 203,058    
Common stock, shares outstanding, end of period at Mar. 31, 2013 31,307,582     31,307,582,000    
Issuance of common stock in lieu of compensation, shares         18,786,000 10,594,000
Stock-based compensation expense 2,203     2,203    
Excess tax deduction from stock options (118)          
Net income (loss) 25,799          
Foreign curency translation adjustment (6,724)   (6,724)      
Interest rate swap (81)   (81)      
Foreign provision 12,451          
Issuance of common stock in exercise of stock options, shares       566,487,000    
Issuance of common stock in exercise of stock options 3,340          
Issuance of restricted stock as deferred compensation to employees and directors       17,416,000    
Balance, end of period at Mar. 31, 2014 $ 250,466 $ 49,863 $ (7,880) $ 208,483    
Common stock, shares outstanding, end of period at Mar. 31, 2014 31,920,865     31,920,865,000